Pharmacy Grand Rounds

Don't Press Your Luck: Re-Evaluation the Role of Vasopressin in Shock

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)
MN-RO-AL-MN-459-MAYO LH

Interactive Video Conference Room(s): 
MN-RO-GO-19-101 BARRETTE LH

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

Each year, septic shock claims more than 40,000 lives in the United States alone. Despite vastly improved detection, treatment, and prevention, septic shock and other shock states are still one of the leading causes of mortality in the intensive care unit. Treatment is multifactorial and targets the source of pathophysiology, but maintenance of blood pressure is one of the cornerstones of treatment to maintain perfusion of vital organs. A plethora of agents are available on the market to achieve this goal, but optimal use of vasopressors is challenging in this dynamic, critically ill population. Despite vasopressin’s availability as a vasopressor for several decades, this presentations aims to address the questions that remain about how to best utilize this unique agent to optimize the outcomes of shock.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Describe the mechanism of vasopressin in shock states with a focus on septic shock
2. Identify current practice variations in vasopressin use in septic shock
3. Examine literature supporting the use of vasopressin in different shock states

Session Announcement

Session Slides

FACULTY INFORMATION

Andrew J. Webb, PharmD
PGY1 Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Andy received a Doctor of Pharmacy degree from the University of Rhode Island. He is a current PGY1 Pharmacy Resident at Mayo Clinic Hospital-Rochester with practice interests in neurology, critical care, and infectious diseases.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Andrew J. Webb, PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will be discussed during this presentation, including:
    • Vasopressin

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS